Cline Scientific AB (publ) (CLINE-B.ST) Research

Based in Mölndal, Sweden, Cline Scientific AB (publ), founded in 2012, is dedicated to pioneering advancements in cancer diagnostics and regenerative medical treatments. A core area of its work involves the development of an allogeneic stem cell therapy, which utilizes induced pluripotent stem (iPS) cells. The company also innovates in surface nanotechnology, applying it to cell-based products and processes to expedite life science projects into clinical development. Furthermore, Cline Scientific maintains a collaborative relationship with AstraZeneca, leveraging its gradient technology.

Market snapshot

Symbol
CLINE-B.ST
Price
$0.07
Day change
0.00%
Market cap
$3.1M
P/E ratio
-0.66x
52-week range
0.0556-0.1795
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Asarina Pharma AB (publ) (ASAP.ST)
  • Bioservo Technologies AB (publ) (BIOS.ST)
  • Bonzun AB (publ) (BONZUN.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Duearity AB (publ) (DEAR.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Pharmiva AB (publ) (PHARM.ST)
  • Redwood Pharma AB (REDW.ST)

Open Cline Scientific AB (publ) (CLINE-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.